Check out this scientific paper.
Not sure if it’s the same 3e10 patry’s is Using, but it does seem to be quite similar in name and mechanism of action.
http://mct.aacrjournals.org/content/molcanther/early/2012/10/01/1535-7163.MCT-12-0476-T.full.pdf
These scientists also made quite a bold statement about the significance of this type drug in cancer therapy in their abstract,
“The use of cell-penetrating bispecific antibodies in targeted molecular therapy will significantly broaden the spectrum of accessible intracellular targets and may have a profound impact in cancer therapy. Mol Cancer Ther; 11(10); 1– 5. !2012 AACR.“
- Forums
- ASX - By Stock
- PAB
- Ann: PAT-DX1 Crosses Blood Brain Barrier to Reduce Tumour Size
Ann: PAT-DX1 Crosses Blood Brain Barrier to Reduce Tumour Size, page-86
-
-
- There are more pages in this discussion • 82 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PAB (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $6.172M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
37 | 34533848 | 0.3¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.4¢ | 25555974 | 16 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
37 | 34533848 | 0.003 |
27 | 36556332 | 0.002 |
12 | 41851998 | 0.001 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.004 | 25555974 | 16 |
0.005 | 10004512 | 8 |
0.006 | 8701466 | 7 |
0.007 | 6601356 | 5 |
0.008 | 665910 | 2 |
Last trade - 16.12pm 15/10/2024 (20 minute delay) ? |
Featured News
PAB (ASX) Chart |
Day chart unavailable
The Watchlist
JBY
JAMES BAY MINERALS LIMITED
Andrew Dornan, Executive Director
Andrew Dornan
Executive Director
SPONSORED BY The Market Online